Insider Trading March 17, 2026

Alight Director Adds $24,600 in Stock as Company Faces Revenue Pressure and Executive Transition

Robert A. Lopes Jr. buys 30,000 shares amid share buybacks, partnership news and multiple analyst downgrades

By Avery Klein ALIT
Alight Director Adds $24,600 in Stock as Company Faces Revenue Pressure and Executive Transition
ALIT

Director Robert A. Lopes Jr. acquired 30,000 shares of Alight, Inc. on March 16, 2026, paying $0.82 per share for a total of $24,600. The purchase increases his direct holdings to 117,219 shares and coincides with company developments including a new collaboration on claims monitoring, the announced departure of the interim CFO, and several analyst cuts following missed revenue guidance and weak quarterly results.

Key Points

  • Director Robert A. Lopes Jr. bought 30,000 Class A shares on March 16, 2026 at $0.82 per share, totaling $24,600.
  • Alight's stock price is $0.74, down 88% year-over-year, trading at a Price/Book of 0.37; management has been repurchasing shares according to InvestingPro.
  • Company updates include a partnership with VB Scout for claims monitoring, the announced departure of Interim CFO Gregory Giometti (through May 2026 or until a replacement is named), and multiple analyst downgrades after missed revenue and earnings expectations.

Insider purchase

On March 16, 2026, Robert A. Lopes Jr., a member of Alight, Inc.'s board of directors (NASDAQ: ALIT), purchased 30,000 shares of the company's Class A common stock at $0.82 per share, a transaction that totaled $24,600. After the trade, Lopes' direct holdings in Alight amount to 117,219 shares, a total that includes restricted stock units that are scheduled to vest in the future.


Current market context

At the time of reporting, Alight's shares were trading at $0.74, representing an 88% decline over the past 12 months and a Price/Book multiple of 0.37. According to InvestingPro, management has been active in share repurchases, and a Fair Value analysis included in that service indicates the stock appears undervalued. The InvestingPro note also references 14 additional ProTips and expanded financial metrics for subscribers.


Corporate developments

On the product front, Alight announced a collaboration with VB Scout to integrate claims monitoring technology into its Worklife platform, which serves more than 30 million people. The partnership is intended to bolster the platform's ability to analyze medical claims and surface potential reimbursements under various voluntary benefit policies.


Management change

The company also disclosed that Interim Chief Financial Officer Gregory Giometti will depart his interim role, remaining in place until May 2026 or until a permanent replacement is appointed. Alight said it is actively seeking an external candidate for the CFO role and expects to announce a successor in the near term.


Analyst reactions and financial outlook

Several brokerages have revised their views on Alight following recent results and guidance. Bank of America Securities reduced its price target after a significant miss on first-quarter 2026 revenue guidance, citing concerns about net revenue retention. Citi downgraded Alight to Neutral from Buy and lowered its price target, citing valuation concerns. Needham moved to Hold from Buy after Alight's fourth-quarter results missed expectations on both revenue and earnings. The company has not issued guidance for 2026, attributing the omission to near-term challenges.


What the transaction means on its face

The director's purchase adds to his stake and comes against a backdrop of buybacks, a strategic partnership aimed at improving claims analytics, the pending CFO transition, and several analyst downgrades tied to recent financial performance and guidance shortfalls. The action is a single data point in the company's ongoing operational and financial story.

Risks

  • Revenue and guidance risk - The company missed first-quarter 2026 revenue guidance and has not provided 2026 guidance, creating uncertainty for investors and analysts; this impacts equity investors and financial services coverage of the stock.
  • Leadership transition risk - The planned departure of Interim CFO Gregory Giometti and the search for an external replacement could create near-term operational or reporting uncertainty affecting investor confidence and corporate finance functions.
  • Market valuation and performance risk - Significant share-price decline (down 88% over the past year) and analyst downgrades point to valuation and execution concerns, affecting stakeholders in the technology and human capital management sectors.

More from Insider Trading

Navitas CFO Sells $1.06M of NVTS Stock Amid Transition and Product Announcements Mar 17, 2026 Astera Labs Director Disposes $325,000 in Stock as Company Posts Strong Q4 Results Mar 17, 2026 GeneDx CEO Sells $1.32M in WGS Stock to Meet RSU Tax Withholding Mar 17, 2026 PACS Group COO Sells $1.24M in Shares as Stock Trades Well Above Analyst Targets Mar 17, 2026 GeneDx CFO Disposes $438K in Stock Following Zero-Strike Option Exercise Mar 17, 2026